Higher ABCA13 levels by qPCR have been associated with better response to neoadjuvant chemotherapy in breast cancer [17] and with longer disease-free survival following chemotherapy in colorectal cancer [18], and this gene was previously reported to be underexpressed in renal cell carcinoma compared to normal tissue [19]. Here, ABCA13 is linked to colorectal cancer.